Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer
Completed · Not applicable
Conditions studied: Ovarian Cancer
In brief
RATIONALE: Diagnostic procedures using the drug radiolabeled folic acid and imaging may be effective in detecting ovarian cancer. PURPOSE: Diagnostic trial to study the effectiveness of radiolabeled folic acid plus imaging in detecting ovarian cancer.
Key facts
- Study ID
- NCT00003763
- Run by
- Endocyte
- People needed
- 35
- Starts
- 1997-12-08
- Expected to finish
- 2000-05-03
- Last updated by the study team
- 2021-09-30
Who can join
Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Indiana University Cancer Center — Indianapolis, Indiana, United States
- Washington University - St. Louis — St Louis, Missouri, United States
- University of Texas - MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.